Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sosei Group Corporation announces the acquisition of Idorsia's pharmaceutical business in Japan and APAC (excluding China). The transaction combines Sosei's leading GPCR-targeted drug discovery platform with Idorsia's clinical development capabilities and profitable commercial operations in the region.
presentation
investor_presentation
58 Pages
Advanced Energy